I think one of the things that's certainly happening in the rare disease community is that it's a very internationally linked community. So as you say, even though there may be only three sites in the world that can treat that particular disease, in fact many of these clinicians will know each other. Now, because we are also part of Orphanet and we're part of those international communities, we are also listing our clinical sites and listing our experts on there, and we have access to others. We have diseases, as David was saying, for which we may have only a dozen people in Canada with that disease, but they actually can be followed and supported by international sites—
On May 2nd, 2013. See this statement in context.